Analysts Lift PT on Zebra Technologies Corporation (ZBRA) Amid Stronger Outlook
Zebra Technologies Corporation (NASDAQ:ZBRA) is one of the
On February 13, TheFly reported that Morgan Stanley lifted the price target on Zebra Technologies Corporation (NASDAQ:ZBRA) from $309 to $323, keeping its Equal Weight rating on the stock.
Morgan Stanley’s analyst Meta Marshall remains positive on ZBRA as the company’s outlook pointed to a reacceleration in 2026 despite concerns on the Q4 print around organic growth rates.
UBS analyst Damian Karas also increased the price target on Zebra Technologies from $310 to $335, with a Buy rating. Karas pointed out that Zebra’s 2026 guidance was ahead of consensus estimates. The company expects its Q1 2026 revenue to be around $1.48 billion at the midpoint, higher than analyst estimates of $1.43 billion. Whereas, the adjusted EPS guidance for FY2026 is estimated to be $18 at the midpoint. The company’s guidance is based on a strong pipeline, ongoing investments in AI-powered solutions for the frontline, and continued momentum in RFID and machine vision technologies.
After a strong fourth quarter driven by robust growth in Asia Pacific and Latin America, and ZBRA’s return to growth in Europe, Zebra Technologies is ready to focus on expansion in healthcare, manufacturing, and retail sectors. With a consensus average price target of $345, ZBRA has an upside of almost 35% as of February 20.
Zebra Technologies Corporation (NASDAQ:ZBRA), along with its subsidiaries, is engaged in the global automatic identification and data capture solutions industry. The company operates in two segments: Connected Frontline and Asset Visibility and Automation.
While we acknowledge the potential of ZBRA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Newmark's In-Line Results: What's Already Priced In?
2 Reasons to Appreciate CDNS and 1 Reason for Caution



